About Nora Mende
Nora Mende is the chief financial officer of Trellis Bioscience. The company is a clinical-stage biotechnology firm that develops native human monoclonal antibodies against hard-to-treat infections. She is the media contact on the company's July 16, 2026 release announcing a $9 million raise.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Nora Mende in the role, so the role may have started earlier or lasted longer.
Trellis Bioscience, Inc. Current
Chief Financial Officer
2026 – Present · Redwood City, CA
Clinical-stage antibody drug developer targeting the bacterial biofilms that shield chronic infections from antibiotics, starting with prosthetic joint infections.
Key Colleagues at Startups
The people Nora Mende works with at each company, as listed on that company's latest Form D.
Trellis Bioscience, Inc. · Form D/A, Oct 29, 2026
LK
Larry Kauvar
CSO and Founder